ArabianBusiness.com - Middle East Business News
Saturday, 21 November 2009 22:59 UAE time

YOUR DIRECTORY /

| Share |

Glaxo Saudi's sole supplier of H1N1 vaccine for now

by This email address is being protected from spam bots, you need Javascript enabled to view it  on Saturday, 07 November 2009
H1N1 FOCUS: Saudi Arabia's vaccination campaign was launched on Saturday and will first focus on pilgrims and health workers.(Getty Images)

British drugmaker GlaxoSmithKline is currently Saudi Arabia's sole supplier of an H1N1 flu vaccine but the kingdom may include other firms for the supply of a nationwide inoculation campaign, the health ministry said.

Saudi Arabia's vaccination campaign was launched on Saturday and will first focus on pilgrims and health workers.

"For the moment, the only vaccine that has been authorised is the GlaxoSmithKline vaccine Pandemrix," health ministry spokesman Khaled Mirghalani told Reuters.

Story continues below
advertisement

"We will in the future get vaccines from other clients, from other companies, as soon as they get approved by the SFDA (Saudi Food and Drug Authority)," he said.

Around 3 million Muslim pilgrims from more than 160 countries take part in the haj in the holy city of Mecca most years, including up to 2 million who travel from abroad. Haj this year will start in during the last week of November.

Disease experts from the United States and Arab countries, including Saudi Arabia, have said waves of the H1N1 flu virus spread by pilgrims travelling to and from Mecca for haj could put pressure on healthcare systems around the world.

The pilgrimage provides perfect conditions for the spread of the H1N1 flu virus, which is transmitted by sneezing and physical contact.

The country will launch later this month a second inoculation campaign aimed at schools, Health Minister Abdullah bin Abdul-Aziz al-Rabeea said on Saturday.

GlaxoSmithKline and Sanofi-Aventis are among some 25 companies producing pandemic vaccine and other drugmakers including Switzerland's Roche Holding are making antivirals for use as a frontline H1N1 drug.

According to the World Health Organization's latest death toll, which is thought to underestimate the total spread of the virus, at least 6,000 people worldwide have died as a result of an H1N1 infection since its discovery earlier this year in Mexico and the United States. (Reuters)

| Share |


READERS' COMMENTS

Disclaimer: The views expressed here by our readers are not necessarily shared by ArabianBusiness.com or its employees.

Click here to post a comment


Add your Comment
All posts are sent to the administrator for review and are published only after approval. ArabianBusiness.com reserves the right to remove any comment at any time for any reason. Please keep your responses appropriate and on topic.
Arabian Business would like to point out that only comments relevant to the story will be published. Any containing personal insults or inappropriate language will not be approved.
Name *
Remember me on this computer
Email *
(Your email address will not be published)
City
Country
Subject *
Comment *
Notify me of further comments


Please click post only once - your comment will not be published immediately.


MORE FROM ARABIANBUSINESS.COM

SHARE PRICE CHECK

 EMAIL ALERTS

  1. Glaxo Smithkline (GSK)

  2. Healthcare


Tell us your story

READER COMMENTS

  1. UAE announces Eid and National Day holidays 02
    21 Nov ' 09 at 10:22
    Is it any wonder that Emiratis are reluctant to work in the private sector? One day extra and no request for early payment of salaries.   More  »
  2. RTA to lease out last batch of retail outlets available on Red Line 01
    21 Nov ' 09 at 14:10
    What happened of Last Minute and their 28 outlets - one on each station?   More  »
  3. Dubai plans start-up help for expat entrepreneurs 01
    21 Nov ' 09 at 11:37
    this is great news really makes sense, especially since Small & Medium Enterprises actually make UAE. I sincerely hope that this is...   More  »

Read all user comments >

Gitex 2009

MORE FROM ARABIANBUSINESS.COM